Trends in Iran Pharmaceutical Market.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

47 citing papers in PubMed.

1. Physicians' Attitudes Toward Unnecessary Medical Services: Ethical and Systemic Challenges in Fourth Level Prevention - Tehran 2024.Medical journal of the Islamic Republic of Iran · 2026
   Article
2. A nationwide study on the consumption and expenditure of osteoporosis medications in Iran during the period from 2001 to 2021.Archives of osteoporosis · 2025
   Article
3. Spectroscopic Screening of Dexamethasone and Cyproheptadine Adulteration in Weight Gaining Products Marketed in Aden, Yemen.Addiction & health · 2024
   Article
4. Drivers of vulnerability to medicine smuggling and combat strategies: a qualitative study based on online news media analysis in Iran.BMC health services research · 2024
   Article
5. Out-of-pocket pharmaceutical expenditure and its determinants among Iranian households with elderly members: a double-hurdle model.Cost effectiveness and resource allocation : C/E · 2024
   Article
6. Opinion of Polish Patients with Epilepsy on Generic Medications.Healthcare (Basel, Switzerland) · 2023
   Article
7. How does external reference pricing work in developing countries: evidence from Iran.Frontiers in pharmacology · 2023
   Article
8. Factors Affecting the Product Life Cycle of Generic Medicines.Iranian journal of pharmaceutical research : IJPR · 2022
   Article
9. Implications of national tax policy on local pharmaceutical production in a southwestern state nigeria - qualitative research for the intersection of national pharmaceutical policy on health systems development.BMC health services research · 2022
   Article
10. Health Systems of Iran and Portugal: A Comparative Study.Medical journal of the Islamic Republic of Iran · 2022
    Article
11. Occurrence, transformation, bioaccumulation, risk and analysis of pharmaceutical and personal care products from wastewater: a review.Environmental chemistry letters · 2022
    Review
12. Pharmaceutical subsidy policy in Iran: a qualitative stakeholder analysis.Health research policy and systems · 2021
    Article
13. Eliciting the public preferences for pharmaceutical subsidy in Iran: a discrete choice experiment study.Journal of pharmaceutical policy and practice · 2021
    Article
14. Mapping Drug Prescription, Polypharmacy, and Pharmaceutical Spending in Older Adults in Iran: A Multilevel Analysis Based on Claims Data.Medical journal of the Islamic Republic of Iran · 2021
    Article
15. The Impact of Inflation and Its Uncertainty on Pharmaceutical Prices: Evidence from Iran.Iranian journal of pharmaceutical research : IJPR · 2021
    Article
16. Assessment of Influential Variables in the Pricing of Locally Manufactured Pharmaceuticals: Current Challenging Situation in Iran.Iranian journal of pharmaceutical research : IJPR · 2021
    Article
17. Policies and Practices Catalyzing the Use of Generic Medicines: A Systematic Search and Review.Ethiopian journal of health sciences · 2021
    Review
18. Short and long term impacts of COVID-19 on the pharmaceutical sector.Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences · 2020
    Article
19. The impact of sanction and healthcare system reform on the healthcare performance and pharmaceutical market in Iran; 2001-2016.Journal of pharmaceutical policy and practice · 2020
    Article
20. Economic and non-economic determinants of Iranian pharmaceutical companies' financial performance: an empirical study.BMC health services research · 2019
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.